Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Februar 2026 20:51 ET | Quelle: Hims

Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

Hims GLP-1 weight loss update: reported $49 compounded semaglutide pill, FDA vs. compounded distinctions, and telehealth access details for 2026
28. Januar 2026 18:03 ET | Quelle: TomorrowRX

TomorrowsRx Telehealth Service Outlines Prescription Access for Compounded Semaglutide and Advanced Tirzepatide Formulations

TomorrowsRx platform details prescription access process for compounded semaglutide & tirzepatide formulations through telehealth evaluation.
10. Juni 2025 19:26 ET | Quelle: Mochi Health

Mochi Health Launches Enhanced Online Platform to Support Medical Weight Loss Patients Nationwide

SAN FRANCISCO, June 10, 2025 (GLOBE NEWSWIRE) -- Mochi Health, a physician-founded telehealth company delivering medical weight loss care directly to patients, announced today the launch of its...
25. April 2025 17:48 ET | Quelle: TMates

TMates Under Review: Affordable GLP-1 Medication Website to Buy Semaglutide, Tirzepatide, Phentermine & More

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why traditional weight loss methods often fail due to metabolic resistance, hormonal imbalances, and emotional...